Luskin A, Griffin NM, Wagele-Steffen A, et al. Decreased exacerbations and hospitalizations in adolescents enrolled in PROSPERO (Prospective Observational Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab). ATS 2017, abstract A5104.
4 van de 5 tuberculosepatiënten hebben geen hardnekkige hoest
mrt 2024 | Bacteriële infecties, Tuberculose